Suchergebnisse - "Toyoda, Hidenori"

PubPharm (920)

1

Validation study of age-independent fibrosis score (Fibrosis-3 index) in patients with metabolic dysfunction-associated steatotic liver disease

enthalten in: Hepatology research : the official journal of the Japan Society of Hepatology | 2024

von Nouso, K. | Kawanaka, M. | Fujii, H. | +34

2

Prognosis of biopsy-confirmed metabolic dysfunction- associated steatotic liver disease : A sub-analysis of the CLIONE study

enthalten in: Clinical and molecular hepatology | 2024

von Iwaki, M. | Fujii, H. | Hayashi, H. | +30

CommentIn: Clin Mol Hepatol. 2024 Apr;30(2):168-170. - PMID 38439189

3

Hepatic inflammation and fibrosis are profiles related to mid-term mortality in biopsy-proven MASLD : A multicenter study in Japan

enthalten in: Alimentary pharmacology & therapeutics | 2024

von Tsutsumi, T. | Kawaguchi, T. | Fujii, H. | +30

4

Impact of body mass index on the prognosis of unresectable HCC patients receiving first-line Lenvatinib or atezolizumab plus bevacizumab

enthalten in: Liver international : official journal of the International Association for the Study of the Liver | 2024

von Rimini, M. | Stefanini, B. | Tada, T. | +75

5

Quantitative measurements of M2BPGi depend on liver fibrosis and inflammation

enthalten in: Journal of gastroenterology | 2024

von Uojima, H. | Yamasaki, K. | Sugiyama, M. | +25

6

Changes in clinical outcomes in Japanese patients with hepatocellular carcinoma due to hepatitis C virus following the development of direct-acting antiviral agents

enthalten in: Journal of gastroenterology and hepatology | 2024

von Ohama, H. | Hiraoka, A. | Tada, T. | +15

7

Clinical usefulness of newly developed prognostic predictive score for atezolizumab plus bevacizumab for hepatocellular carcinoma

enthalten in: Cancer reports (Hoboken, N.J.) | 2024

von Ohama, H. | Hiraoka, A. | Tada, T. | +42

8

Comparative analysis of the therapeutic outcomes of atezolizumab plus bevacizumab and lenvatinib for hepatocellular carcinoma patients aged 80 years and older : Multicenter study

enthalten in: Hepatology research : the official journal of the Japan Society of Hepatology | 2024

von Hatanaka, T. | Kakizaki, S. | Hiraoka, A. | +45

9

Severe hepatic steatosis promotes increased liver stiffness in the early stages of metabolic dysfunction-associated steatotic liver disease

enthalten in: Liver international : official journal of the International Association for the Study of the Liver | 2024

von Kumada, T. | Toyoda, H. | Ogawa, S. | +10

10

iATT liver fat quantification for steatosis grading by referring to MRI proton density fat fraction : a multicenter study

enthalten in: Journal of gastroenterology | 2024

von Hirooka, M. | Ogawa, S. | Koizumi, Y. | +13

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[92]